Loading news...
The consensus price target hints at a 29.3% upside potential for Auna S.A. (AUNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today announced the formal execution of an addendum to its existing Public-Private Partnership (“PPP”) agreement with EsSalud, Peru's Social Health Insurance agency. This agreement facilitates the commencement of the construction phase of the Torre Trecca project in Lima. The execution of the addendum is an important milestone f.
Here is how Auna S.A. (AUNA) and COMPASS Pathways PLC Sponsored ADR (CMPS) have performed compared to their sector so far this year.
Auna S.A. (AUNA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Auna S.A. (AUNA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
GOLD, NIC, SPFI, AUNA and FOX have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2026.
Auna S.A. (AUNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please.
Auna (NYSE: AUNA - Get Free Report) and Q Biomed (OTCMKTS:QBIO - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends. Volatility and Risk Auna has a beta of 2.26,
Shares of Auna S.A. (NYSE: AUNA - Get Free Report) have received a consensus rating of "Hold" from the six ratings firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the
Auna (NYSE: AUNA - Get Free Report) and NewGenIvf Group (NASDAQ: NIVF - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Earnings and Valuation This table compares Auna and
Auna S.A. (NYSE: AUNA - Get Free Report) has been assigned a consensus rating of "Reduce" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average 12 month
Auna S.A. ( AUNA ) Q3 2025 Earnings Call November 21, 2025 8:00 AM EST Company Participants Ana Maria Mora Jesús Zamora Leon - President, CEO & Executive Chairman of the Board Gisele Ferrero - CFO & Executive VP Conference Call Participants Mauricio Cepeda - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to Auna's Third Quarter 2025 Earnings Conference Call. My name is Eric and I'll be the operator for today's call.
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 (“third quarter 2025” or “3Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q25 Consolidated Highlights Consoli.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America (“Sojitz”), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region's la.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru's Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership (“PPP”). When completed, Torre Trecca is.
Auna (NYSE: AUNA - Get Free Report) and Selectis Health (OTCMKTS:GBCS - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Volatility and Risk Auna has a beta of
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today the closing of a US$765 million debt refinancing that significantly strengthens its capital structure by extending debt maturities, lowering interest expenses, and improving cash flow generation to further invest in the Company's various strategic growth initiatives. The Company and Oncosalud S.A.C., as co-issuer.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal amount of 8.750% Senior Secured Notes due 2032 (the “Notes”) to be issued by the Company and Oncosalud S.A.C. (“Oncosalud” and, together with the Company, the “Co-Issuers”), as co-issuers, which includes (i) U.S.$328,500,000 in aggregate principal amount of Notes offere.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA), a public limited liability company (société anonyme) incorporated and existing under the laws of Luxembourg, having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B267590 (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the e.